By The Associated Press
NYT Health
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries.
Published date: June 29, 2020 at 02:25PM
AP
New York Times article
No comments:
Post a Comment